GASTROENTEROLOGICAL SOCIETY OF AUSTRALIA

Chronic hepatitis C virus (HCV) infection is a major public health challenge for Australia, affecting about 120 000 people who are at risk of progressive liver fibrosis leading to cirrhosis, liver failure and hepatocellular carcinoma (HCC)... Before the introduction of direct-acting antiviral (DAA) therapy, HCV infection was a common cause of liver disease (and liver cancer) requiring liver transplantation in Australia. It remains an important cause of liver-related morbidity and mortality in people who progress to cirrhosis.

Primary location: Melbourne Australia